10 Best Robotics Stocks to Buy According to Billionaires

4. Stryker Corporation (NYSE:SYK)

No. of Billionaire Investors: 13

No. of Hedge Fund Holders: 70

Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services in Medical and Surgical, Neurotechnology, Orthopedics, and Spine. Its robotics arm, Mako, develops spinal and knee devices, among other products. Stryker also specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows. The company assists surgeons in visualizing and reviewing patients via Apple Vision Pro.

On March 21, Needham analyst Mike Matson reiterated a Buy rating on SYK shares, with a price target of $442. Matson retains a positive view of SYK shares following the acquisition of Inari Medical, a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. Matson has raised FY25 and FY26 revenue estimates for Stryker, driven by Inari Medical’s revenue streams. Moreover, Stryker continues to experience solid demand for its Mako robotic-assisted surgery systems, with record installations in the U.S. and worldwide. The company posted a strong sales growth of 10% year-over-year in 2024. Whereas the adjusted earnings per share increased by 15% from a year ago. Stryker expects an organic sales growth of 8% to 9% in 2025.